Abstract:C67 Perixosome Proliferator-Activated Receptor gamma (PPARg) transcription factor plays an indispensable role in adipogenesis, and has been linked to obesity and type 2 diabetes. In addition, it plays a significant role in inflammation, artheroschlerosis and cancer. We have employed the well characterized mouse fibroblastic cell line, 3T3-L1, to map the binding sites of PPARg, as well as it’s heterodimeric parther, RXR during adipocyte differentiation. Using chromatin immunoprecipitation paired-end ditags method, we have identified high-confidence binding sites for these two factors. After sequencing both libraries, we performed saturation analysis using Hill-function function and found that each library was approximately 66% saturated. Through Monte-Carlo analysis, we identified 2953 PPARg PET clusters and 5142 RXR PET clusters as significant, denoting the sets of PPARg and RXR binding regions, respectively. A subset of both binding sites was validated by realtime PCR. For both libraries the saturation using the Hill-equation was approx 66%. (as expected). We observed a good correlation between binding of PPARg and RXR within an interval of 500bp around a PPARg site. We found that binding of both PPARg and RXR was significantly enriched in the close proximity (2000bp) around known transcription start sites but no such enrichment was observed around the gene 3’ end. The co-occurrence of both binding sites proved to be an additional measure of confidence, since PPARg sites alone were validated to a much lesser degree. Comparative location analysis indicated that simultaneous binding of PPARg and RXR is essential for transcription of their target genes. In addition, expression profile analysis coupled with RNA interference for PPARg and PPARg/RXR binding site data, we have identified direct target genes that are dependent on PPARg transcriptional activity for their expression. The microarray data was analyzed using 3-way ANOVA to eliminate batch effects. We identified 1846 genes that showed PPARg-dependent differential expression during the course of adipocyte differentiation (FDR 5%). The identified genes significantly over-represented biological functions connected to lipid and fatty acid metabolism. Combining the ChIP-PET data and the expression profiles we identified a number of genes as novel direct targets of PPARg. Exploiting this information, we integrated RNA interference to characterize PPARg direct target genes essential for adipogenesis, insulin sensitization, and white/brown fat determination. In addition, ongoing analysis using of our binding site data around putative PPARg/RXR response elements shows a significant enrichment of a number of candidate transcription factor binding sites, at frequencies much greater than by chance. Further analysis using ChIP and RNA interference for these transcription factors will state the importance of these co-factors in adipocyte biology. Taken together, this genome-wide analysis of PPARg and RXR binding sites suggests a complex but definable rules governing gene regulation, adipogenesis and insulin sensitization.

Adipose Tissue Peroxisomal Lipid Synthesis Orchestrates Obesity and Insulin Resistance through LXR-Dependent Lipogenesis

Regulation Of Insulin Resistance And Adiponectin Signaling In Adipose Tissue By Liver X Receptor Activation Highlights A Cross-Talk With Ppar Gamma

Adipose Tissue-Specific PPARγ Deficiency Increases Resistance to Oxidative Stress

Impaired adipose expansion caused by liver X receptor activation is associated with insulin resistance in mice fed a high-fat diet.

<strong><b></b></strong>Impaired Adipose Tissue Expansion Caused by LXR Activation is Associated with Insulin Resistance in HFD Mice

Dietary control of peripheral adipose storage capacity through membrane lipid remodelling

The global perspective on peroxisome proliferator-activated receptor (PPAR) in ectopic fat deposition: A review

Adipose Tissue-Derived PRXL2A Suppresses Hepatic Lipogenesis

PPARg/RXR Transcriptional Circuitry Governing Adipocyte Biology

Liver ACOX1 regulates levels of circulating lipids that promote metabolic health through adipose remodeling

Hepatocyte-Specific PEX16 Abrogation in Mice Leads to Hepatocyte Proliferation, Alteration of Hepatic Lipid Metabolism, and Resistance to High-Fat Diet (HFD)-Induced Hepatic Steatosis and Obesity

Crosstalk between CYP2E1 and PPARα substrates and agonists modulate adipose browning and obesity

Enhanced Peroxisomal Β-Oxidation Metabolism in Visceral Adipose Tissues of High-Fat Diet-Fed Obesity-Resistant C57BL/6 Mice.

Adipocyte IRE1α promotes PGC1α mRNA decay and restrains adaptive thermogenesis

De-novo Identification of PPARgamma/RXR Binding Sites and Direct Targets During Adipogenesis.

LXR regulation of adipose tissue inflammation during obesity is associated with dysregulated macrophage function

Adipose tissue lipolysis is regulated by PAQR11 via altering protein stability of phosphodiesterase 4D

Unbalanced lipolysis results in lipotoxicity and mitochondrial damage in peroxisome-deficient Pex19 mutants

Adipocyte LDL receptor–related protein–1 expression modulates postprandial lipid transport and glucose homeostasis in mice

Mechanism of Obesity-Related Lipotoxicity and Clinical Perspective

Surplus Fatty Acid Synthesis Increases Oxidative Stress in Adipocytes and Induces Lipodystrophy